Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (941-950 of 993) with videos related to

Pageof 100
Sort By:
Cancers|April 13, 2023
Critical Appraisal of Leibovich 2018 and GRANT Models for Prediction of Cancer-Specific Survival in Non-Metastatic Chromophobe Renal Cell CarcinomaMattia Luca Piccinelli, Simone Morra, Stefano Tappero, et al.
NEJM Evidence|February 6, 2024
Abiraterone and Olaparib for Metastatic Castration-Resistant Prostate CancerNoel W Clarke, Andrew J Armstrong, Antoine Thiery-Vuillemin, et al.
Journal of Clinical Medicine|October 16, 2024
The Effect of Surgical Resection on Cancer-Specific Mortality in Pelvic Soft Tissue Sarcoma According to Histologic Subtype and StageMattia Luca Piccinelli, Andrea Baudo, Stefano Tappero, et al.
European Urology|May 27, 2020
Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate CancerCameron Herberts, Andrew J Murtha, Simon Fu, et al.
European Urology|April 25, 2022
Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysisPawel Rajwa, Benjamin Pradere, Giorgio Gandaglia, et al.
European Urology Oncology|September 25, 2025
Prognostic Significance of the Cytoplasmic Expression of UDP-glucuronosyltransferase 2B17 in Localized Prostate Cancer: Insights from the Canadian Prostate Cancer Biomarker Network and PROCURE Multi-institutional CohortsAshwini Uchil, Louis Lacombe, Hélène Hovington, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2016
Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1Matthew Smith, Johann De Bono, Cora Sternberg, et al.
Cancers|October 16, 2024
Demographic and Clinical Characteristics of Malignant Solitary Fibrous Tumors: A SEER Database AnalysisMattia Luca Piccinelli, Kyle Law, Reha-Baris Incesu, et al.
Journal of Surgical Oncology|April 12, 2024
Contemporary conditional cancer-specific survival rates in surgically treated nonmetastatic primary urethral carcinomaSimone Morra, Lukas Scheipner, Andrea Baudo, et al.
Urologic Oncology|January 18, 2025
Cancer-specific mortality after radical prostatectomy versus radiotherapy in incidental prostate cancerFrancesco Di Bello, Lukas Scheipner, Andrea Baudo, et al.
Pageof 100

Showing results (941-950 of 993) with videos related to

Sort By:
Pageof 100
Cancers|April 13, 2023
Critical Appraisal of Leibovich 2018 and GRANT Models for Prediction of Cancer-Specific Survival in Non-Metastatic Chromophobe Renal Cell CarcinomaMattia Luca Piccinelli, Simone Morra, Stefano Tappero, et al.
NEJM Evidence|February 6, 2024
Abiraterone and Olaparib for Metastatic Castration-Resistant Prostate CancerNoel W Clarke, Andrew J Armstrong, Antoine Thiery-Vuillemin, et al.
Journal of Clinical Medicine|October 16, 2024
The Effect of Surgical Resection on Cancer-Specific Mortality in Pelvic Soft Tissue Sarcoma According to Histologic Subtype and StageMattia Luca Piccinelli, Andrea Baudo, Stefano Tappero, et al.
European Urology|May 27, 2020
Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate CancerCameron Herberts, Andrew J Murtha, Simon Fu, et al.
European Urology|April 25, 2022
Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysisPawel Rajwa, Benjamin Pradere, Giorgio Gandaglia, et al.
European Urology Oncology|September 25, 2025
Prognostic Significance of the Cytoplasmic Expression of UDP-glucuronosyltransferase 2B17 in Localized Prostate Cancer: Insights from the Canadian Prostate Cancer Biomarker Network and PROCURE Multi-institutional CohortsAshwini Uchil, Louis Lacombe, Hélène Hovington, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2016
Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1Matthew Smith, Johann De Bono, Cora Sternberg, et al.
Cancers|October 16, 2024
Demographic and Clinical Characteristics of Malignant Solitary Fibrous Tumors: A SEER Database AnalysisMattia Luca Piccinelli, Kyle Law, Reha-Baris Incesu, et al.
Journal of Surgical Oncology|April 12, 2024
Contemporary conditional cancer-specific survival rates in surgically treated nonmetastatic primary urethral carcinomaSimone Morra, Lukas Scheipner, Andrea Baudo, et al.
Urologic Oncology|January 18, 2025
Cancer-specific mortality after radical prostatectomy versus radiotherapy in incidental prostate cancerFrancesco Di Bello, Lukas Scheipner, Andrea Baudo, et al.
Pageof 100